BUZZ- NZ-listed shares of Pacific Edge jump on higher U.S. price for Triage Plus

Reuters
Sep 10
BUZZ- NZ-listed shares of <a href="https://laohu8.com/S/PFGTF">Pacific Edge</a> jump on higher U.S. price for Triage Plus

** New Zealand listed shares of Pacific Edge PEB.NZ rise as much as 17.7% to A$0.166, their highest level since October 8, 2024

** Cancer diagnostics firm says US Centers for Medicare & Medicaid Services $(CMS)$ have recommended a higher final price for co's urothelial cancer diagnostics product - Cxbladder Triage Plus1 -than their proposed price in April

** CMS sets the amount co will receive in reimbursements for all patients with Medicare and Medicare Advantage insurance for the product

** New recommended price is US$1,328.32, up from the US$1,018 proposed in April, co says

** Stock posts its biggest intraday pct gain since April 29

** Around 2.5 mln shares change hands, 4.8x the 30-day average trading volume

** Last up 9.9%, bringing YTD gains to 24%

(Reporting by Shruti Agarwal in Bengaluru)

((Shruti.Agarwal@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10